Platelets-to-lymphocyte ratio and esophageal cancer

Antonios Athanasiou, Michael Spartalis, Eleftherios Spartalis


We read with great interest the recent publication by Deng et al. (1) published in the March 2018 issue of Journal of Thoracic Disease. The authors have performed a meta-analysis in order to examine the role of platelet to lymphocyte ratio (PLR) in the prognosis of esophageal cancer and also to evaluate the relationship with tumor pathological characteristics.